MLECW
Moolec Science S.A.
NASDAQ · Healthcare · Biotechnology · LU
$0.02
+10.56%Margins
Gross margin
-8.2%
EBITDA margin
-66.5%
EBIT margin
-116.7%
Net margin
-105.7%
FCF margin
-78.1%
-296.1%
Return on equity
-26.4%
Return on assets
-36.7%
Return on invested capital
0.25x
Asset turnover
-$5.7M
Cash from operations
$4.48
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2025